Nothing Special   »   [go: up one dir, main page]

Phan et al., 2001 - Google Patents

Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors

Phan et al., 2001

View HTML @Full View
Document ID
14870262795165707448
Author
Phan J
Steadman D
Koli S
Ding W
Minor W
Dunlap R
Berger S
Lebioda L
Publication year
Publication venue
Journal of Biological Chemistry

External Links

Snippet

Thymidylate synthase (TS) is a major target in the chemotherapy of colorectal cancer and some other neoplasms. The emergence of resistance to the treatment is often related to the increased levels of TS in cancer cells, which have been linked to the elimination of TS …
Continue reading at www.jbc.org (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes

Similar Documents

Publication Publication Date Title
Phan et al. Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors
Yang et al. Structure of the Methanococcus jannaschii mevalonate kinase, a member of the GHMP kinase superfamily
Guo et al. Crystal structure of ClpA, an Hsp100 chaperone and regulator of ClpAP protease
Liu et al. Crystal structure of the gephyrin-related molybdenum cofactor biosynthesis protein MogA from Escherichia coli
Alvarez et al. Triose-phosphate isomerase (tim) of the psychrophilic bacteriumvibrio marinus: Kinetic and structural properties
Moon et al. Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1
Sawaya et al. The structure of β-carbonic anhydrase from the carboxysomal shell reveals a distinct subclass with one active site for the price of two
Sulzenbacher et al. Crystal structure of Streptococcus pneumoniae N-acetylglucosamine-1-phosphate uridyltransferase bound to acetyl-coenzyme A reveals a novel active site architecture
Liszczak et al. Structure of a ternary Naa50p (NAT5/SAN) N-terminal acetyltransferase complex reveals the molecular basis for substrate-specific acetylation
Zhang et al. Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase: Comparisons with NADPH-cytochrome P450 oxidoreductase
Fu et al. The structure of a binary complex between a mammalian mevalonate kinase and ATP: insights into the reaction mechanism and human inherited disease
Peneff et al. The crystal structures of Apo and complexed Saccharomyces cerevisiae GNA1 shed light on the catalytic mechanism of an amino-sugar N-acetyltransferase
Hisano et al. Crystal structure of the (R)-specific enoyl-CoA hydratase from Aeromonas caviae involved in polyhydroxyalkanoate biosynthesis
Umland et al. A new crystal structure of deoxyhypusine synthase reveals the configuration of the active enzyme and of an enzyme· NAD· inhibitor ternary complex
Appleby et al. The structure of human 5′-deoxy-5′-methylthioadenosine phosphorylase at 1.7 Å resolution provides insights into substrate binding and catalysis
Savvides et al. Kinetics and crystallographic analysis of human glutathione reductase in complex with a xanthene inhibitor
Smith et al. The structure of mammalian serine racemase: evidence for conformational changes upon inhibitor binding
Smolle et al. A new level of architectural complexity in the human pyruvate dehydrogenase complex
Shi et al. 1.85-Å Resolution Crystal Structure of Human Ornithine Transcarbamoylase Complexed withN-Phosphonacetyl-l-ornithine: CATALYTIC MECHANISM AND CORRELATION WITH INHERITED DEFICIENCY
Lake et al. The Crystal Structure of the Escherichia coliMobA Protein Provides Insight into Molybdopterin Guanine Dinucleotide Biosynthesis
Ganichkin et al. Structure and catalytic mechanism of eukaryotic selenocysteine synthase
Thoden et al. Molecular structure of galactokinase
Goto et al. Crystal structures of Δ1-piperideine-2-carboxylate/Δ1-pyrroline-2-carboxylate reductase belonging to a new family of NAD (P) H-dependent oxidoreductases: conformational change, substrate recognition, and stereochemistry of the reaction
Maita et al. Structural basis of biopterin-induced inhibition of GTP cyclohydrolase I by GFRP, its feedback regulatory protein
Nakamura et al. Dynamic, ligand-dependent conformational change triggers reaction of ribose-1, 5-bisphosphate isomerase from Thermococcus kodakarensis KOD1